Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Adiels

Showing results (91-100 of 124) with videos related to

Pageof 13
Sort By:
The Lancet Regional Health. Europe|May 10, 2021
Severe COVID-19 in people with type 1 and type 2 diabetes in Sweden: A nationwide retrospective cohort studyAidin Rawshani, Elin Allansson Kjölhede, Araz Rawshani, et al.
European Heart Journal|January 22, 2026
Risk-weighted apoB: a novel summary metric outperforming traditional lipid biomarkers in predicting coronary heart diseaseMichaela B Rehman, Elias Björnson, Martin Adiels, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 29, 2015
Kinetic and Related Determinants of Plasma Triglyceride Concentration in Abdominal Obesity: Multicenter Tracer Kinetic StudyJan Borén, Gerald F Watts, Martin Adiels, et al.
Ebiomedicine|December 6, 2020
Longitudinal plasma protein profiling of newly diagnosed type 2 diabetesAnders Gummesson, Elias Björnson, Linn Fagerberg, et al.
Diabetes, Obesity & Metabolism|January 27, 2021
Effects of liraglutide on the metabolism of triglyceride-rich lipoproteins in type 2 diabetesMarja-Riitta Taskinen, Elias Björnson, Niina Matikainen, et al.
Global Epidemiology|November 30, 2022
COVID-19 in people aged 18-64 in Sweden in the first year of the pandemic: Key factors for severe disease and deathAnnika Rosengren, Mia Söderberg, Christina E Lundberg, et al.
Journal of Internal Medicine|May 25, 2022
Severe COVID-19 in people 55 and older during the first year of the pandemic in SwedenAnnika Rosengren, Christina E Lundberg, Mia Söderberg, et al.
Diabetes, Obesity & Metabolism|April 12, 2019
Role of apolipoprotein C-III overproduction in diabetic dyslipidaemiaMartin Adiels, Marja-Riitta Taskinen, Elias Björnson, et al.
Diabetes|June 9, 2009
ApoCIII-enriched LDL in type 2 diabetes displays altered lipid composition, increased susceptibility for sphingomyelinase, and increased binding to biglycanAnne Hiukka, Marcus Ståhlman, Camilla Pettersson, et al.
Journal of Clinical Lipidology|January 10, 2020
Impact of proprotein convertase subtilisin/kexin type 9 inhibition with evolocumab on the postprandial responses of triglyceride-rich lipoproteins in type II diabetic subjectsMarja-Riitta Taskinen, Elias Björnson, Linda Andersson, et al.
Pageof 13

Showing results (91-100 of 124) with videos related to

Sort By:
Pageof 13
The Lancet Regional Health. Europe|May 10, 2021
Severe COVID-19 in people with type 1 and type 2 diabetes in Sweden: A nationwide retrospective cohort studyAidin Rawshani, Elin Allansson Kjölhede, Araz Rawshani, et al.
European Heart Journal|January 22, 2026
Risk-weighted apoB: a novel summary metric outperforming traditional lipid biomarkers in predicting coronary heart diseaseMichaela B Rehman, Elias Björnson, Martin Adiels, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 29, 2015
Kinetic and Related Determinants of Plasma Triglyceride Concentration in Abdominal Obesity: Multicenter Tracer Kinetic StudyJan Borén, Gerald F Watts, Martin Adiels, et al.
Ebiomedicine|December 6, 2020
Longitudinal plasma protein profiling of newly diagnosed type 2 diabetesAnders Gummesson, Elias Björnson, Linn Fagerberg, et al.
Diabetes, Obesity & Metabolism|January 27, 2021
Effects of liraglutide on the metabolism of triglyceride-rich lipoproteins in type 2 diabetesMarja-Riitta Taskinen, Elias Björnson, Niina Matikainen, et al.
Global Epidemiology|November 30, 2022
COVID-19 in people aged 18-64 in Sweden in the first year of the pandemic: Key factors for severe disease and deathAnnika Rosengren, Mia Söderberg, Christina E Lundberg, et al.
Journal of Internal Medicine|May 25, 2022
Severe COVID-19 in people 55 and older during the first year of the pandemic in SwedenAnnika Rosengren, Christina E Lundberg, Mia Söderberg, et al.
Diabetes, Obesity & Metabolism|April 12, 2019
Role of apolipoprotein C-III overproduction in diabetic dyslipidaemiaMartin Adiels, Marja-Riitta Taskinen, Elias Björnson, et al.
Diabetes|June 9, 2009
ApoCIII-enriched LDL in type 2 diabetes displays altered lipid composition, increased susceptibility for sphingomyelinase, and increased binding to biglycanAnne Hiukka, Marcus Ståhlman, Camilla Pettersson, et al.
Journal of Clinical Lipidology|January 10, 2020
Impact of proprotein convertase subtilisin/kexin type 9 inhibition with evolocumab on the postprandial responses of triglyceride-rich lipoproteins in type II diabetic subjectsMarja-Riitta Taskinen, Elias Björnson, Linda Andersson, et al.
Pageof 13